SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950134-04-004611
Filing Date
2004-04-02
Accepted
2004-04-02 16:57:06
Documents
2
Period of Report
2004-03-31
Items
Item 12: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO 8-K f97874e8vkza.htm 8-K/A 7807
3 EXHIBIT 99.1 f97874exv99w1.txt EX-99.1 17516
  Complete submission text file 0000950134-04-004611.txt   26948
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-22570 | Film No.: 04714722
SIC: 2833 Medicinal Chemicals & Botanical Products